Prolactinomas are the most common pituitary tumor histotype, with microprolactinomas
being prevalent in women and macroprolactinomas in men. Hyperprolactinemia is among …

Prolactinomas, the most prevalent type of neuroendocrine disease, account for
approximately 40% of all pituitary adenomas. The most important clinical problems …

Chronic estrogen treatment induces prolactin (PRL)-secreting pituitary tumors in laboratory
animals. To determine earlier events of tumorigenesis, we studied cell proliferation in the …

Objective To characterise distinctive clinical features of giant prolactinomas in women.
Design A multicentre, retrospective case series and literature review. Methods We collected …

This review encompasses the diagnostic features of malignancy, the routinely observable
prognostic features and the prognostic and predictive features emerging from research …

Much recent debate has focused on the optimal classification of epithelial neuroendocrine
tumors (NETs). Multiple different systems of terminology, grading, and staging have been …

Adrenocorticotrophic hormone (ACTH)‐secreting pituitary adenomas give rise to a severe
endocrinological disorder, comprising Cushing's disease, with multifaceted clinical …

Purpose The aim of the study was to assess the effect of dopamine agonist (DA) withdrawal,
the current recurrence rate of hyperprolactinemia, and possible factors that predict …

Neuroendocrine tumours (NETs) represent a heterogenous group of tumours, with diversity
in their primary tumour sites, functional status (ie hormone secreting or non-functional) and …

In neuroendocrine tumors (NETs), proliferation markers, especially Ki-67, have become
increasingly important. This study was designed to examine the reproducibility of Ki-67 for …